|
基于“护场”理论探讨中西医结合防治乳腺癌肝转移的思路
|
Abstract:
乳腺癌发病人数逐年攀升,相较于其他部位转移的患者,乳腺癌肝转移患者通常预后较差。“护场”指正邪交争过程中,正气约束邪气,使之不至于深陷或扩散而形成的局部作肿范围。中医认为,癌毒侵袭转移与护场不守有关。护场的微观基础为免疫微环境,能识别和杀伤癌变细胞,而免疫逃逸在促进肿瘤转移方面发挥重要作用。基于“护场”理论,笔者从中西医结合角度分析乳腺癌肝转移病机,并提出从清除癌毒、固护护场以及先安未受邪之地三个方面进行干预,为中西医结合防治乳腺癌肝转移提供新思路。
The incidence of breast cancer is increasing year by year. Compared with patients with other metastatic sites, patients with liver metastasis of breast cancer usually have a worse prognosis. “Field protection” refers to the local swelling range formed by the restraint of positive qi on evil qi in the process of the conflict between good and evil, so that it will not be deep or diffuse. Traditional Chinese medicine believes that the invasion and metastasis of cancer virus are related to the failure to field protection. The microscopic basis of the field protection is the immune microenvironment, which can recognize and kill cancerous cells, and immune escape plays an important role in promoting tumor metastasis. Based on the theory of “field protection”, the author analyzed the pathogenesis of breast cancer liver metastasis from the perspective of integrated traditional Chinese and Western medicine, and proposed three aspects of intervention: removing cancer poison, strengthening the field and protecting the uninfected area first, providing new ideas for the prevention and treatment of breast cancer liver metastasis with integrated traditional Chinese and Western medicine.
[1] | 江庆良, 李恒宇. 乳腺癌肝转移外科治疗进展[J]. 中国普通外科杂志, 2024, 33(5): 683-696. |
[2] | 王竞翊, 马哿, 夏添松, 王水. 乳腺癌肝转移的机制及治疗[J]. 中国肿瘤外科杂志, 2020, 12(4): 375-379. |
[3] | 于秀辰, 孟艳娇, 丁千, 雷超奇, 赵谏. 护场理论探微[J]. 中国中医基础医学杂志, 2013, 19(11): 1268-1270. |
[4] | 范洪桥, 刘丽芳, 熊家青, 周亮. 从中医学角度探讨护场与恶性肿瘤的传舍[J]. 辽宁中医杂志, 2019, 46(9): 1853-1854. |
[5] | 丁忱, 孙彬栩, 贾英杰. “护场”理论指导下中西医结合治疗恶性肿瘤[C]//第十五届全国中西医结合肿瘤学术大会论文集. 2017: 157-158. https://kns.cnki.net/kcms2/article/abstract?v=k15566fjT2nRu5AtdYFN5ZoBKFfSqaTKKwPNrm-tqA9szBP01hAruW7VEGQkKqU0bBV1sIstN2VKdtZItnCQZTI1a8JQlku3tqmYVqpG3sdTnQdEz8f4VaP6yvY-5EHJ16jVHsgr0NIpNIAFxTuWNd4uCq35B0n0EFklecEWkdmE0kYGDpWlZOuh8mZY9_zLXvuFsFlSdME=&uniplatform=NZKPT&language=CHS, 2024-10-23. |
[6] | Brook, N., Brook, E., Dharmarajan, A., Dass, C.R. and Chan, A. (2018) Breast Cancer Bone Metastases: Pathogenesis and Therapeutic Targets. The International Journal of Biochemistry & Cell Biology, 96, 63-78. https://doi.org/10.1016/j.biocel.2018.01.003 |
[7] | 姚志华, 李柳, 施丽娜, 程海波. 基于癌毒病机理论辨治乳腺癌肝转移[J]. 辽宁中医药大学学报, 2024, 26(5): 112-115. |
[8] | Thill, M., Kolberg-Liedtke, C., Albert, U.-S., Banys-Paluchowski, M., Bauerfeind, I., Blohmer, J.-U., et al. (2023) AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023. Breast Care, 18, 305-314. https://pubmed.ncbi.nlm.nih.gov/37900553/ https://doi.org/10.1159/000531579 |
[9] | Zacharakis, N., Chinnasamy, H., Black, M., Xu, H., Lu, Y., Zheng, Z., et al. (2018) Immune Recognition of Somatic Mutations Leading to Complete Durable Regression in Metastatic Breast Cancer. Nature Medicine, 24, 724-730. https://doi.org/10.1038/s41591-018-0040-8 |
[10] | 李雅雯, 周瑞娟, 邱利红, 卢超逸, 徐乐勤, 卢晓惠. 护场理论在乳腺相关疾病中的应用[J]. 中国中西医结合外科杂志, 2024, 30(3): 411-414. |
[11] | 杨辉, 孙敏, 刘曦. 疏肝益肾方加减对乳腺癌患者免疫功能及生活质量的影响[J]. 现代中西医结合杂志, 2020, 29(33): 3683-3687. |
[12] | 葛宏升, 周军, 雷霆. 中药联合常规化疗对乳腺癌术后患者免疫功能及远期转移率的影响[J]. 现代中西医结合杂志, 2019, 28(14): 1544-1547. |
[13] | 杨辉, 孙敏, 刘曦. 疏肝益肾方加减对乳腺癌患者免疫功能及生活质量的影响[J]. 现代中西医结合杂志, 2020, 29(33): 3683-3687. |